MyFinsight
Home
About
Contact
goss: the income statement
Download
Download image
Comprehensive loss
-$48,240K
(-48.36%↓ Y/Y)
Other comprehensive
loss
-$19K
(98.89%↑ Y/Y)
Net loss
-$48,221K
(-56.55%↓ Y/Y)
Unrealized gain (loss) on
marketable securities
$111K
(-79.71%↓ Y/Y)
Other income, net
$2,954K
(-31.11%↓ Y/Y)
PHILDCommercial Expenses
Subject To...
$167K
PAHCommercial Expenses
Subject To...
$922K
PHILDResearch And Development
Services Expenses...
$3,882K
PAHResearch And Development
Services Expenses...
$4,270K
PHILDResearch And Development
Services Performance...
$1,152K
PAHResearch And Development
Services Performance...
$2,903K
Interest income
$687K
(59.77%↑ Y/Y)
Foreign currency
translation
-$130K
(94.25%↑ Y/Y)
Loss before
provision (benefit) for...
-$48,221K
(-51.00%↓ Y/Y)
Total other income,
net
$893K
(-54.99%↓ Y/Y)
Revenue From Contracts
With Collaborators
$13,294K
Interest expense
$2,748K
(0.51%↑ Y/Y)
Effects Of Exchange Rate
-$2K
Loss from operations
-$49,114K
(-44.80%↓ Y/Y)
Total revenue
$13,294K
(40.23%↑ Y/Y)
Total operating
expenses
$62,408K
(43.80%↑ Y/Y)
General and
administrative
$9,390K
(10.44%↑ Y/Y)
In process
research and development
$7,476K
Research and development
$45,542K
(30.50%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)